Jonathan Bullman

959 total citations
22 papers, 640 citations indexed

About

Jonathan Bullman is a scholar working on Physiology, Molecular Biology and Psychiatry and Mental health. According to data from OpenAlex, Jonathan Bullman has authored 22 papers receiving a total of 640 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Physiology, 5 papers in Molecular Biology and 5 papers in Psychiatry and Mental health. Recurrent topics in Jonathan Bullman's work include Pain Mechanisms and Treatments (3 papers), Bipolar Disorder and Treatment (3 papers) and Pharmacological Effects and Toxicity Studies (3 papers). Jonathan Bullman is often cited by papers focused on Pain Mechanisms and Treatments (3 papers), Bipolar Disorder and Treatment (3 papers) and Pharmacological Effects and Toxicity Studies (3 papers). Jonathan Bullman collaborates with scholars based in United Kingdom, United States and Germany. Jonathan Bullman's co-authors include Robert Lai, Jonathan Appleby, Thor Ostenfeld, Antonella Napolitano, Pauline Williams, Mike Aylott, Boris A. Chizh, Jie Wang, Jeffrey Price and Praveen Anand and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Pain.

In The Last Decade

Jonathan Bullman

22 papers receiving 614 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jonathan Bullman United Kingdom 14 267 155 118 118 116 22 640
David André Barrière France 12 268 1.0× 85 0.5× 148 1.3× 118 1.0× 84 0.7× 20 731
Stephen J. Medhurst United Kingdom 13 605 2.3× 275 1.8× 236 2.0× 253 2.1× 208 1.8× 13 1.0k
Prem K.G. Chandran United States 12 318 1.2× 183 1.2× 171 1.4× 220 1.9× 235 2.0× 29 785
Wuping Sun China 19 371 1.4× 157 1.0× 245 2.1× 98 0.8× 66 0.6× 54 923
Gricelda Hernandez United States 6 490 1.8× 216 1.4× 292 2.5× 237 2.0× 82 0.7× 8 896
Krisztina Pohóczky Hungary 15 194 0.7× 304 2.0× 143 1.2× 141 1.2× 53 0.5× 28 678
Jorge E. Torres‐López Mexico 17 501 1.9× 49 0.3× 220 1.9× 224 1.9× 134 1.2× 32 806
Devin M. Swanson United States 12 294 1.1× 297 1.9× 218 1.8× 170 1.4× 41 0.4× 14 707
K. Schaffler United States 12 167 0.6× 40 0.3× 74 0.6× 65 0.6× 83 0.7× 51 415
Shailen K. Joshi United States 13 326 1.2× 115 0.7× 147 1.2× 138 1.2× 87 0.8× 15 531

Countries citing papers authored by Jonathan Bullman

Since Specialization
Citations

This map shows the geographic impact of Jonathan Bullman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan Bullman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan Bullman more than expected).

Fields of papers citing papers by Jonathan Bullman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan Bullman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan Bullman. The network helps show where Jonathan Bullman may publish in the future.

Co-authorship network of co-authors of Jonathan Bullman

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan Bullman. A scholar is included among the top collaborators of Jonathan Bullman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan Bullman. Jonathan Bullman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bissonnette, Robert, et al.. (2018). Systemic Pharmacokinetics, Safety, and Preliminary Efficacy of Topical AhR Agonist Tapinarof: Results of a Phase 1 Study. Clinical Pharmacology in Drug Development. 7(5). 524–531. 30 indexed citations
2.
Yang, Jiansong, Peiming Ma, Jonathan Bullman, Andrew Nicholls, & Chao Chen. (2018). Adjustment of the area under the concentration curve by terminal rate constant for bioequivalence assessment in a parallel‐group study of lamotrigine. British Journal of Clinical Pharmacology. 85(3). 563–569. 6 indexed citations
3.
Napolitano, Antonella, Kim Brown, Jonathan Bullman, et al.. (2018). Target engagement and cellular fate of otelixizumab: a repeat dose escalation study of an anti‐CD3ε mAb in new‐onset type 1 diabetes mellitus patients. British Journal of Clinical Pharmacology. 85(4). 704–714. 10 indexed citations
4.
Berges, Aliénor, Jonathan Bullman, Stewart Bates, et al.. (2015). Ozanezumab Dose Selection for Amyotrophic Lateral Sclerosis by Pharmacokinetic-Pharmacodynamic Modelling of Immunohistochemistry Data from Patient Muscle Biopsies. PLoS ONE. 10(2). e0117355–e0117355. 6 indexed citations
5.
Bullman, Jonathan, et al.. (2015). The relative bioavailability of 2 prototype fixed‐dose combination formulations for amlodipine and rosuvastatin in healthy white and Chinese subjects. Clinical Pharmacology in Drug Development. 5(2). 131–140. 3 indexed citations
6.
Ostenfeld, Thor, Alok Krishen, Robert Lai, et al.. (2014). A Randomized, Placebo-controlled Trial of the Analgesic Efficacy and Safety of the p38 MAP Kinase Inhibitor, Losmapimod, in Patients With Neuropathic Pain From Lumbosacral Radiculopathy. Clinical Journal of Pain. 31(4). 283–293. 34 indexed citations
7.
Tompson, Debra, et al.. (2014). Effect of Hemodialysis on Pharmacokinetics of Ezogabine/Retigabine and its N-Acetyl Metabolite in Patients with End Stage Renal Disease. Current Clinical Pharmacology. 9(4). 319–325. 3 indexed citations
8.
Ridler, Khanum, Roger N. Gunn, Graham E. Searle, et al.. (2014). Characterising the plasma-target occupancy relationship of the neurokinin antagonist GSK1144814 with PET. Journal of Psychopharmacology. 28(3). 244–253. 20 indexed citations
9.
Ostenfeld, Thor, et al.. (2012). Human microdose evaluation of the novel EP1 receptor antagonist GSK269984A. British Journal of Clinical Pharmacology. 74(6). 1033–1044. 13 indexed citations
10.
Hay, Justin L., et al.. (2012). Pharmacokinetics and central nervous system effects of the novel dual NK1/NK3 receptor antagonist GSK1144814 in alcohol‐intoxicated volunteers. British Journal of Clinical Pharmacology. 75(5). 1328–1339. 10 indexed citations
11.
12.
13.
Bullman, Jonathan, et al.. (2011). Effects of lamotrigine and phenytoin on the pharmacokinetics of atorvastatin in healthy volunteers. Epilepsia. 52(7). 1351–1358. 29 indexed citations
14.
Palmer, James A., Robert Lai, Nicola Thomas, et al.. (2009). 701 RANDOMISED, PLACEBO‐CONTROLLED, PARALLEL‐GROUP STUDY OF THE EFFECT OF SB‐705498, A TRPV1 RECEPTOR ANTAGONIST, ON PAIN FOLLOWING THIRD MOLAR TOOTH EXTRACTION. European Journal of Pain. 13(S1). 1 indexed citations
15.
Chizh, B.A., James A. Palmer, Robert Lai, et al.. (2009). 702 A RANDOMISED, TWO‐PERIOD CROSS‐OVER STUDY TO INVESTIGATE THE EFFICACY OF THE TRPV1 ANTAGONIST SB‐705498 IN ACUTE MIGRAINE. European Journal of Pain. 13(S1). 20 indexed citations
16.
Chizh, Boris A., Antonella Napolitano, Jie Wang, et al.. (2007). The effects of the TRPV1 antagonist SB-705498 on TRPV1 receptor-mediated activity and inflammatory hyperalgesia in humans. Pain. 132(1). 132–141. 199 indexed citations
17.
Sidhu, Jagdev, Sarah A. Job, Jonathan Bullman, et al.. (2006). Pharmacokinetics and tolerability of lamotrigine and olanzapine coadministered to healthy subjects. British Journal of Clinical Pharmacology. 61(4). 420–426. 24 indexed citations
18.
Chizh, B.A., Antonio Napolitano, Mike O’Donnell, et al.. (2006). (765). Journal of Pain. 7(4). S42–S42. 10 indexed citations
19.
Theis, Jochen G.W., Jagdev Sidhu, Joanne Palmer, et al.. (2005). Lack of Pharmacokinetic Interaction between Oxcarbazepine and Lamotrigine. Neuropsychopharmacology. 30(12). 2269–2274. 19 indexed citations
20.
Bullman, Jonathan, et al.. (2004). Pharmacokinetic profile of a new form of sumatriptan tablets in healthy volunteers. Current Medical Research and Opinion. 20(6). 803–809. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David André Barrière Breakdown of academic impact, for papers by Stephen J. Medhurst Breakdown of academic impact, for papers by Prem K.G. Chandran Breakdown of academic impact, for papers by Wuping Sun Breakdown of academic impact, for papers by Gricelda Hernandez Breakdown of academic impact, for papers by Krisztina Pohóczky Breakdown of academic impact, for papers by Jorge E. Torres‐López Breakdown of academic impact, for papers by Devin M. Swanson Breakdown of academic impact, for papers by K. Schaffler Breakdown of academic impact, for papers by Shailen K. Joshi
Rankless by CCL
2026